First Light Acquisition Group LLC 13D and 13G filings for Calidi Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 06:05 am Sale | 2023-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | First Light Acquisition Group LLC | 2,864 11.000% | -18,601 (-86.66%) | Filing |
| 2023-02-10 5:23 pm Sale | 2022-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | First Light Acquisition Group LLC | 21,465 38.400% | -16,916 (-44.07%) | Filing |
| 2022-02-11 06:17 am Purchase | 2021-12-31 | 13G | Calidi Biotherapeutics, Inc. CLDI | First Light Acquisition Group LLC | 38,381 16.000% | 38,381 (New Position) | Filing |